First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry
European Journal of Clinical Investigation · 2025
DOI: 10.1111/eci.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Antonio Tonutti und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Hauptthemen laut MEDLINE: Scleroderma, Systemic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Primary heart involvement (pHI) is an overlooked and poorly characterised complication of systemic sclerosis (SSc), associated with the risk of heart failure, arrhythmia and death. Despite consensus definition by the World Scleroderma Foundation/Heart Failure Association (WSF/HFA), diagnostic criteria and risk factors remain poorly elucidated.
Methods
Out of 1922 patients in the Italian national SPRING registry, we excluded those with potentially confounding conditions according to WSF/HFA, and those with incomplete ECG or echocardiographic assessment, resulting in 600 subjects with clearly defined parameters to intercept SSc‐pHI. Cross‐sectional and longitudinal analyses were performed to identify factors associated with pHI.
Results
ECG and/or echocardiographic signs of SSc‐pHI were identified in 25% of patients at enrollment and were associated with older age (OR 1.04; 95% CI 1.02–1.06), diffuse cutaneous SSc (OR 1.85; 95% CI 1.05–3.26) and intestinal symptoms (OR 1.79; 95% CI 1.03–3.08). Diastolic dysfunction (62%) and conduction disturbances (34%) were the most frequent phenotypes, while diffuse hypokinesia with reduced ejection fraction was the least common (3%). During follow‐up, new‐onset signs of pHI were observed in an additional 25% of patients, particularly in those with skeletal muscle involvement (HR 2.83; 95% CI 1.01–7.73). Conclusions pHI is a severe complication potentially affecting one‐quarter of patients with SSc. Early detection is crucial, particularly in those with diffuse skin fibrosis, muscular involvement and intestinal manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
- Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
- Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
- IRCSS INRCA, Ancona, Italy.
- Rheumatology Clinic 'Madonna dello Scoglio', Cotronei, Crotone, Italy.
- Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena and Reggio Emilia School of Medicine, Modena, Italy.
ORCID-Profile: Antonio Tonutti, Giovanna Cuomo, Marco Fornaro, Marco Di Battista
Zitieren
APA
Tonutti, A., Motta, F., De Angelis, R., Cipolletta, E., Ferri, C., Bajocchi, G., Bellando-Randone, S., Bruni, C., Orlandi, M., Zanframundo, G., Foti, R., Cuomo, G., Ariani, A., Rosato, E., Lepri, G., Girelli, F., Zanatta, E., Bosello, S. L., Cavazzana, I., …, & Govoni, M. (2025). First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70094
Vancouver
Tonutti A, Motta F, De Angelis R, Cipolletta E, Ferri C, Bajocchi G, et al. First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.70094
BibTeX
@article{Tonutti2025,
author = {Tonutti, Antonio and Motta, Francesca and De Angelis, Rossella and Cipolletta, Edoardo and Ferri, Clodoveo and Bajocchi, Gianluigi and Bellando-Randone, Silvia and Bruni, Cosimo and Orlandi, Martina and Zanframundo, Giovanni and Foti, Rosario and Cuomo, Giovanna and Ariani, Alarico and Rosato, Edoardo and Lepri, Gemma and Girelli, Francesco and Zanatta, Elisabetta and Bosello, Silvia Laura and Cavazzana, Ilaria and Ingegnoli, Francesca and Cacciapaglia, Fabio and Murdaca, Giuseppe and Abignano, Giuseppina and Pettiti, Giorgio and Rossa, Alessandra Della and Caminiti, Maurizio and Iuliano, Anna Maria and Ciano, Giovanni and Beretta, Lorenzo and Bagnato, Gianluca and Lubrano, Ennio and De Andres, Ilenia and Idolazzi, Luca and Saracco, Marta and Agnes, Cecilia and Campochiaro, Corrado and Fornaro, Marco and Lumetti, Federica and Spinella, Amelia and Magnani, Luca and De Luca, Giacomo and Codullo, Veronica and Visalli, Elisa and Iandoli, Carlo and Gigante, Antonietta and Pellegrino, Greta and Pigatto, Erika and Lazzaroni, Maria Grazia and De Lorenzis, Enrico and Mennillo, Gianna and Di Battista, Marco and Pagano-Mariano, Giuseppa and Furini, Federica and Vultaggio, Licia and Parisi, Simone and Peroni, Clara Lisa and Bianchi, Gerolamo and Fusaro, Enrico and Sebastiani, Gian Domenico and Govoni, Marcello},
title = {First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry},
journal = {European Journal of Clinical Investigation},
year = {2025},
doi = {10.1111/eci.70094}
}
EUVIMED